ancer would now be diagnosed with Stage III. Thus, the 10-year survival rate for those with Stage II breast cancer improved, from 66 percent (5th edition) to 72 percent (6th edition). For those with Stage III, the 10-year survival rate also improved, from 30 percent to 36 percent.
The 6th edition classification system has been required for use for cases diagnosed since January 1, 2003.
The study's lead author is Eugene Kim, an undergraduate at Case Western University, in collaboration Sanghvi; Choong R. Kim, M.D., adjunct clinical faculty at OHSU and a physician at St. John Medical Center; Carol Marquez, M.D., associate professor of radiation medicine, OHSU; and Charles R. Thomas, Jr., M.D., professor and chair of radiation medicine, OHSU.
Page: 1 2 Related medicine news :1
Contact: Rachel MacKnight
Oregon Health & Science University
. American Cancer Society to hold third annual Virtual Relay For Life in Second Life2
. Cancer research summaries3
. Cancer on the agenda of the Portuguese EU Council Presidency4
. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research5
. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients6
. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy7
. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival8
. Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer9
. Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma10
. Margaret Foti receives AACR Award for Leadership and Extraordinary Achievements in Cancer Research11
. Cancer-fighting foods, supplements explored in day-long symposium, March 25